Company intelligence / Profile preview

Chiltern Medicare

Aylesbury, Buckinghamshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Chiltern Medicare was a private UK healthcare company that appears to have operated as a commercial supplier/distributor of in vitro diagnostic and related healthcare products rather than as a therapeutic drug developer. Publicly available references associate the company with urine test strips and clinical laboratory supply listings, indicating a focus on diagnostic products for healthcare use. The legal entity was incorporated in the United Kingdom in 2013 and later dissolved in April 2024. There is no evidence that the company maintained a drug pipeline, proprietary therapeutic platform, or clinical-stage biopharmaceutical programs.

Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Chiltern Medicare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chiltern Medicare.

Explore the full profile